Equities

Tiziana Life Sciences Ltd

Tiziana Life Sciences Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.931
  • Today's Change0.001 / 0.11%
  • Shares traded473.41k
  • 1 Year change+59.15%
  • Beta0.4367
Data delayed at least 15 minutes, as of Nov 11 2024 18:06 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

As of last trade, Tiziana Life Sciences Ltd (TLSA:NAQ) traded at 0.931, 127.07% above the 52 week low of 0.41 set on Apr 15, 2024.
52-week range
Today
0.41Apr 15 20241.74Aug 12 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.94
High1.27
Low0.9001
Bid0.931
Offer0.9598
Previous close0.93
Average volume247.26k
Shares outstanding110.66m
Free float78.88m
P/E (TTM)--
Market cap102.91m USD
EPS (TTM)-0.1726
USD
Data delayed at least 15 minutes, as of Nov 11 2024 18:06 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.